Cargando…
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Autores principales: | Kim, Iris, Morphew, Tricia, Chou, Christine, Ehwerhemuepha, Louis, Galant, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263224/ https://www.ncbi.nlm.nih.gov/pubmed/37321447 http://dx.doi.org/10.1016/j.anai.2023.06.009 |
Ejemplares similares
-
COVID-19 infection may trigger poor asthma control in children
por: Chou, Christine C., et al.
Publicado: (2022) -
Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma
por: Galant, Stanley Paul, et al.
Publicado: (2022) -
Evaluating the impact of coronavirus disease 2019 on asthma morbidity: A comprehensive analysis of potential influencing factors
por: Guijon, Olga L., et al.
Publicado: (2021) -
SARS- CoV-2 infection presented as acute exacerbation of bronchial Asthma
por: Raina, Parul, et al.
Publicado: (2020) -
Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort
por: Marsteller, Nathan L., et al.
Publicado: (2021)